Uzbekistan Launches 330 Pharmaceutical Facilities Worth $1 Billion
The share of locally produced medicines and other pharmaceutical products is planned to reach 70%
In recent years, Uzbekistan has commissioned 330 new pharmaceutical production facilities with a total value of $1 billion.
An additional $1.2 billion has been allocated to projects in the 'Tashkent Biopharm City' cluster and pharmaceutical free economic zones in the Andijan, Namangan, Jizzakh, and Tashkent regions. The plan to meet domestic demand through local production aims to increase its share to 70%.
During a meeting with workers in the medical and pharmaceutical sectors, Shavkat Mirziyoyev also announced the expansion of digital solutions in public and private clinics and pharmacies. The next step will be the introduction of artificial intelligence capabilities to assist doctors and nurses.
